Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEXRAR: DEXamethasone in Revision ARthroplasty: A Randomised, Blinded, 2-group Clinical Trial

NCT02884180 is registered in ClinicalTrials.gov with Daniel Hägi-Pedersen as lead sponsor.

NCT NCT02884180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02884180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEXRAR: DEXamethasone in Revision ARthroplasty: A Randomised, Blinded, 2-group Clinical Trial
Lead sponsor
Daniel Hägi-Pedersen
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2017
Completion date
March 31, 2025
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative